Hydroxo-b12 Pbf Mdv (calif recalls
The FDA has published 2 recalls involving Hydroxo-b12 Pbf Mdv (calif since 2017. The latest was reported on 24 May 2017. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 24 May 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why hydroxo-b12 pbf mdv (calif is recalled
Companies
By year
All hydroxo-b12 pbf mdv (calif recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Hydroxo-B12 Pbf Mdv (Calif) 1MG/ML Inj, Injection, 1mg/mL recalled | Key Pharmacy and Compounding Center | Sterility | Nationwide |
| Drug | CLASS II | Hydroxo-B12 Pbf Mdv (Calif) 10MG/ML Inj, Injection, 10mg/mL recalled | Key Pharmacy and Compounding Center | Sterility | Nationwide |
Should you stop taking Hydroxo-b12 Pbf Mdv (calif?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.